Fujimoto Co., Ltd.
Records under this name other than the patents Fujimoto Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,782,383 | Prophylactic and therapeutic agent for attention-deficit/hyperactivity disorder Lapsed on the fee record Ended Oct 10, 2025 · From the USPTO record | Lapsed on the fee record | Ended Oct 10, 2025 | From the USPTO record |
| US 8,318,799 | Therapeutic agent for substance dependence Formerly held Lapsed on the fee record Ended Nov 27, 2024 · From the USPTO record | Lapsed on the fee record | Ended Nov 27, 2024 | From the USPTO record |
| US 8,178,686 | Process for preparing optically active aminopentane derivative, intermediate and process for preparing intermediate Lapsed on the fee record Ended May 15, 2024 · From the USPTO record | Lapsed on the fee record | Ended May 15, 2024 | From the USPTO record |
| US 7,807,840 | Process for preparing optically active aminopentane derivative, intermediate and process for preparing intermediate Lapsed on the fee record Ended Oct 5, 2022 · From the USPTO record | Lapsed on the fee record | Ended Oct 5, 2022 | From the USPTO record |
| US 8,512,744 | Sustained release micropellets and process for producing the same Lapsed on the fee record Ended Aug 20, 2021 · From the USPTO record | Lapsed on the fee record | Ended Aug 20, 2021 | From the USPTO record |
| US 6,380,229 | 2-(N-cyanoimino)thiazolidin-4-one derivatives Term ended Term ended Jul 11, 2021 · From the USPTO record | Term ended | Term ended Jul 11, 2021 | From the USPTO record |
| US 6,391,914 | Optically active aminopentane derivatives Term ended Ended no later than Jun 16, 2020 · From the USPTO record | Term ended | Ended no later than Jun 16, 2020 | From the USPTO record |
| US 6,214,859 | Ethylamine derivatives Term ended Term ended Jul 12, 2019 · From the USPTO record | Term ended | Term ended Jul 12, 2019 | From the USPTO record |
| US 6,667,328 | Therapeutic agents for diabetes Lapsed on the fee record Ended Dec 23, 2015 · From the USPTO record | Lapsed on the fee record | Ended Dec 23, 2015 | From the USPTO record |
| US 7,825,158 | Therapeutic agent for substance dependence Formerly held Lapsed on the fee record Ended Nov 2, 2014 · From the USPTO record | Lapsed on the fee record | Ended Nov 2, 2014 | From the USPTO record |